John Simard's most recent trade in XBiotech Inc was a trade of 1,026,228 Stock Option done . Disclosure was reported to the exchange on March 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 1,026,228 | 1,896,609 | - | - | Stock Option | |
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Jan 2025 | 2,470,355 | 870,381 | - | - | Convertible Loan Agreement | |
| XBiotech Inc | Simard John | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jan 2024 | 2,470,355 | 3,840,736 | - | - | Convertible Loan Agreement | |
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.45 per share. | 07 Oct 2021 | 39,286 | 3,923,166 (13%) | 0% | 12.5 | 489,111 | Common Stock |
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.90 per share. | 07 Oct 2021 | 21,125 | 3,873,166 (13%) | 0% | 12.9 | 272,523 | Common Stock |
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.77 per share. | 07 Oct 2021 | 18,000 | 3,973,166 (14%) | 0% | 12.8 | 229,939 | Common Stock |
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.83 per share. | 07 Oct 2021 | 10,875 | 3,962,452 (13%) | 0% | 12.8 | 139,526 | Common Stock |
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.08 per share. | 04 Oct 2021 | 23,681 | 3,987,384 (14%) | 0% | 13.1 | 309,864 | Common Stock |
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.66 per share. | 04 Oct 2021 | 14,218 | 3,973,166 (14%) | 0% | 12.7 | 180,058 | Common Stock |
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 12.53 per share. | 04 Oct 2021 | 10,714 | 3,962,452 (13%) | 0% | 12.5 | 134,259 | Common Stock |
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.23 per share. | 28 Sep 2021 | 19,684 | 4,011,065 (14%) | 0% | 13.2 | 260,488 | Common Stock |
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.07 per share. | 28 Sep 2021 | 18,558 | 4,030,749 (14%) | 0% | 13.1 | 242,464 | Common Stock |
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 13.41 per share. | 28 Sep 2021 | 16,396 | 4,049,307 (14%) | 0% | 13.4 | 219,801 | Common Stock |
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 14.27 per share. | 28 Sep 2021 | 6,263 | 4,065,703 (14%) | 0% | 14.3 | 89,364 | Common Stock |
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 14.81 per share. | 23 Sep 2021 | 29,890 | 4,071,966 (14%) | 0% | 14.8 | 442,790 | Common Stock |
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 14.49 per share. | 23 Sep 2021 | 11,418 | 4,101,856 (14%) | 0% | 14.5 | 165,409 | Common Stock |
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 14.68 per share. | 23 Sep 2021 | 9,892 | 4,113,274 (14%) | 0% | 14.7 | 145,220 | Common Stock |
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.14 per share. | 20 Sep 2021 | 19,669 | 4,123,166 (14%) | 0% | 15.1 | 297,757 | Common Stock |
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.24 per share. | 20 Sep 2021 | 16,860 | 4,142,835 (14%) | 0% | 15.2 | 256,913 | Common Stock |
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 15.06 per share. | 20 Sep 2021 | 13,471 | 4,159,695 (14%) | 0% | 15.1 | 202,914 | Common Stock |
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 18.15 per share. | 14 Jul 2021 | 50,000 | 4,173,166 (14%) | 0% | 18.1 | 907,350 | Common Stock |
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Mar 2021 | 500,000 | 0 | - | - | Stock options | |
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.50 per share. | 22 Mar 2021 | 500,000 | 4,223,166 (14%) | 1% | 7.5 | 3,750,000 | Common Shares |
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | 28 Jan 2021 | 500,000 | 500,000 | - | - | Stock Options | ||
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | 28 Jan 2021 | 150,000 | 150,000 | - | - | Stock Options | ||
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | 28 Jan 2021 | 89,260 | 110,740 | - | - | Stock Options | ||
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | 28 Jan 2021 | 13,484 | 61,516 | - | - | Stock Options | ||
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | 28 Jan 2021 | 1,875 | 48,125 | - | - | Stock Options | ||
| XBiotech Inc | John Simard | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 18 Sep 2020 | 500,000 | 3,723,166 (13%) | 1% | - | Common Stock |